How did PEG's revenue and expenses shift in Q4 2024?

Pfizer's (PFE) revenue and expenses in Q4 2024 showed significant shifts, with total revenues amounting to $51.7 billion and total expenses reaching $34.4 billion. This resulted in a net income of $17.3 billion for the quarter. The substantial revenue and expense figures indicate the company's active business operations and its ability to generate substantial profits.

|code|Ticker|Name|Date|Cost of Goods Sold|Total Revenue|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|PFE|PFE.N|Pfizer|2024 Q1|3.379E9|1.4879E10|3.123E9|169|
|PFE|PFE.N|Pfizer|2024 Q2|3.3E9|1.3283E10|4.8E7|169|
|PFE|PFE.N|Pfizer|2024 Q3|5.263E9|1.7702E10|4.473E9|169|
|PFE|PFE.N|Pfizer|2024 Q4|5.909E9|1.7763E10|4.18E8|169|